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Abstract: The fight against cancer represents a great challenge for researchers and, for this reason, 
the search for new promising drugs to improve cancer treatments has become inevitable. Oceans, 
due to their wide diversity of marine species and environmental conditions have proven to be 
precious sources of potential natural drugs with active properties. As an example, in this context 
several studies performed on sponges, tunicates, mollusks, and soft corals have brought evidence 
of the interesting biological activities of the molecules derived from these species. Also, 
echinoderms constitute an important phylum, whose members produce a huge number of 
compounds with diverse biological activities. In particular, this review is the first attempt to 
summarize the knowledge about starfishes and their secondary metabolites that exhibited a 
significant anticancer effect against different human tumor cell lines. For each species of starfish, the 
extracted molecules, their effects, and mechanisms of action are described. 
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1. Introduction 
Over the years, cancer has remained the second leading cause of death worldwide [1]. Cancer is 
a complex disease, which arises from an interplay between genetic and environmental factors and 
characterized by the uncontrolled growth and spread of cells that acquire the ability to overcome cell 
death, by evading apoptosis. The loss of apoptotic control allows cancer cells to survive longer and 
to accumulate a huge number of mutations which can improve the invasive capability during tumor 
progression, promote angiogenesis, deregulate cell proliferation, and interfere with differentiation 
[2]. Due to its peculiar characteristics, the cancer rate endures despite all the attempts to prevent 
tumor disorders and the development of new therapies. Thus, the fight against cancer is the main 
challenge for researchers all over the world, which make every effort to maximize tumor control, 
prolong survival and improve quality of life for patients [3]. However, the prompt development of 
resistance to chemotherapeutic drugs, beside the high toxicity usually associated with some cancer 
chemotherapy drugs and their adverse side-effects, leads to the needs to search for novel anti-tumor 
compounds, capable of overcome these problems. In this regard, natural products seem to be an 
attractive source for the development of new drugs, thanks to their capability to strike multiple 
targets with reduced side effects and their effectiveness against several cancer types [4,5]. Natural 
compounds derive from various sources such as plants, animals, and microorganisms. Most of them 
have been approved and play a key role in the treatment of human diseases [6]. 
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Recently, natural compounds of marine origin have given rise to emerging interest in 
researchers. The oceans constitute the largest habitat of the earth, rich of organisms with high 
biological and chemical diversity. An interesting branch of pharmaceutical sciences, marine 
pharmacology, focuses on the substances derived from marine species of plants and animals with 
active pharmacological properties [7], generally not found in terrestrial natural products. Hence, due 
to the hostile characteristics of marine environment, such as extreme temperatures, continuous 
variations in salinity and pressure and the overcoming effects of mutation, bacteria, and viral 
pathogens, marine organisms developed appropriate mechanisms of adaptation. One of them is the 
production of biologically active secondary metabolites, which can be considered potent chemical 
weapons that marine organisms release if necessary [8,9]. Echinoderms are marine invertebrates 
widely diffused all over the world. There are approximately 7000 extant echinoderm species, 
included into five well-defined taxonomic classes: Crinoidea (sea lilies and feather stars); Asteroidea 
(starfishes); Ophiuroidea (basket stars and brittle stars); Holothuroidea (sea cucumbers), and 
Echinoidea (sea urchins, sand dollars, and sea biscuits) [10]. Echinoderms are an important resource 
of natural products, which showed to have a significant positive impact on human health. Among 
them, one of the best examples is surely represented by sea cucumbers, a very promising group of 
marine invertebrates that during these last decades have gained the attention from researchers 
worldwide. The active compounds found in these animals are various and include polysaccharides, 
phospholipids and glycolipids and especially triterpene glycosides or saponins. A lot of studies have 
revealed their excellent biological effects and nutritive value, their beneficial influence on human 
health, and pharmacological potential, as recently reviewed by Khotimchenko and Pangestut [11,12]. 
The present review aims to focus the attention onto another interesting group of echinoderms, the 
starfishes or sea stars, which represent one of the most promising sources of natural compounds 
thanks to their variety of species and the value of their products. The class Asteroidea includes 
approximately 1600 extant species and according to the classification of Blake (1987), seven orders 
are known, Brisingida, Forcipulatida, Notomyotida, Paxillosida, Spinulosida, Valvatida and 
Velatida, beside two extinct ones, Calliasterellidae and Trichasteropsida. Starfishes are distributed in 
all the world’s oceans at all depths, from the intertidal to the abyssal [13]. They are characterized by 
a star-shaped body plan consisting of a central disc and multiple radiating arms, the number of which 
varies from 5 to 40. Their bony calcified skin protects them from most predators, and usually they 
have impressive colors that disguise them or frighten away potential enemies. Moreover, as 
mentioned before, the presence of particular substances in the sea star’s body represents another 
important defense strategy. Steroidal glycosides are the predominant metabolites present in 
starfishes. These compounds have been subdivided into three main groups based on their chemical 
structures: oligoglycosides (known as asterosaponins), cyclic steroidal glycosides, and glycosides of 
polyhydroxylated steroids. Polyhydroxysteroidal glycosides from starfish possess peculiar structural 
characteristics, which is a polyhydroxylated steroidal aglycone (displaying four to nine hydroxyl 
groups) linked to one or two monosaccharide units [14,15]. Steroidal glycosides from starfishes, 
especially asterosaponins, showed a wide spectrum of biological activities, including cytotoxic, 
hemolytic, antibacterial, anti-inflammatory, antitumor and cancer-preventing effects [16,17]. 
The goal of this review is to present and summarize the information relative to natural 
compounds derived from starfishes that demonstrated a relevant cytotoxic and anti-tumor effect 
against different types of human cancer cell lines. Their effects and mechanisms of action are also 
presented if reported by authors. For each species, the general characteristics, the extracted molecules 
and their biological potential will be described. An overview of the tested molecules is showed in 
Table 1.  
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Table 1. Taxonomy of starfishes and the extracted molecules evaluated for their biological activities 
Species Bioactive Molecules 
Order Paxillosida 
Family Astropectinide 
Astropecten 
polyacanthus 
Steroids: Astropectenols A–D 
5α-cholest-7-ene-3β,6α-diol 
5α-cholest-8(14)-ene-3β,7α-diol 
5α-cholest-7,9(11)-diene-3β-ol 
Glycosylated polyhydroxysteroid: Polyacanthoside A 
Triseramide 
(20R,24S)-3β,6α,8,15β,24-pentahydroxy-5α-cholestane 
Marthasteroside B 
Psilasteroside 
Astropecten 
monacanthus 
Asterosaponins: Astrosteriosides A–D; 
Psilasteroside; Marthasteroside B 
Craspidaster 
hesperus 
Polyhydroxysteroidal glycosides: Hesperuside A–C 
Novaeguinoside A 
Family Ctenodiscidae 
Ctenodiscus 
crispatus 
(22E,24ξ)-26,27-bisnor-24-methyl-5α-cholest-22-en 3β,5,6β,15α,25-pentol 25-O-sulfate 
(22E,24R,25R)-24-methyl-5α-cholest-22-en-3β,5,6β,15α,25,26-hexol 26-O-sulfate 
(28R)-24-ethyl-5α-cholesta-3β,5,6β,8,15α,28,29-heptaol-24-sulfate 
(25S)-5α-cholestane-3β,5,6β,15α,16β,26-hexaol 
Δ7-sitosterol 
Order Forcipulatida 
Family Asteriidae 
Asterias amurensis Cerebrosides 
Leptasterias 
ochotensis 
Asterosaponins: Leptasteriosides A–F 
Asterogenins: (23S)-6α,23-Dihydroxy-5 α-cholesta-9(11),20(21)-dien-3 β-yl sulfate, sodium salt; 
(22E)-6α-Hydroxy-5 α-cholesta-9(11),20(22)-dien-23-one-3 β-yl sulfate, sodium salt 
Sulfated steroid monoglycosides: Leptaochotensosides A–C 
Sulfated polyhydroxylated steroid: (24S)-5α-cholestane 3β,6β,15α,24-tetraol 24-O-sulfate 
Lethasterias fusca 
Lethasteriosides A, B 
Thornasteroside A 
Anasteroside A 
Luidiaquinoside 
Order Spinulosida 
Family Echinasteridae 
Echinaster 
luzonicus 
Luzonicoside A, Luzonicoside D 
Henricia leviuscula Leviusculoside G 
Order Valvatida 
Family Acanthasteridae 
Acanthaster planci 
Plancitoxin protein 
Asterosaponin Acanthaglycoside G 
Pentareguloside G 
Acanthaglycoside A 
Maculatoside (or luidiaglycoside B) 
Plancisides A–C 
Family Archasteridae 
Archaster typicus 
Archasterosides A, B 
Regularoside A 
Family Asterinidae 
Asterina pectinifera 
(25S)-5α-cholestane-3β,6α,7α,8,15α,16β-hexahydroxyl-26-O-14′Z-eicosenoate 
(25S)-5α-cholestane-3β,6α,7α,8,15α,16β,26-heptol 
(25S)-5α-cholestane-3β,4β,6α,7α,8,15α,16β,26-octol 
(25S)-5α-cholestane-3β,4β,6α,7α,8,15β,16β,26-octol 
Cholest-7-en-3-sodium sulfate  
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(24S)-5α-cholestane-3β,6α,8,15α,24-pentol 
Asterosaponins P1-2 
Cyclin B 
Polysaccarides 
Family Asteropseidae 
Asteropsis carinifera 
Steroidal biglycosides: Cariniferosides A–F 
Asterosaponins: Asteropsiside A, Regularoside A, Thornasteroside A 
Family Goniasteridae 
Hippasteria 
phrygiana (H. 
kurilensis) 
Hippasteriosides A–D 
Phrygiasterol 
Borealoside C 
Family Ophidiasteridae 
Certonardoa 
semiregularis 
Certonardosterols 
Certonardosides A–J 
Certonardosides K–N 
Certonardosides P2 and I3 
Narcissia 
canariensis 
Glycosphingolipids: Ophidiacerebrosides 
 
Family Oreasteridae 
Anthenea chinensis Polyhydroxysteroidal glycosides: Anthenoside A, Anthenosides B–K 
Anthenea sibogae Anthenosides S1–S6 
Anthenea aspera 
Anthenosides E, G, J, K, S1, S4, S6 
Anthenosides A1 and A2 
Choriaster 
granulatus 
Granulatosides D and E, Linckoside L4, Echinasteroside B, Echinasterosides C, E and F, desulfated 
Echinasteroside A, 22,23-Dihydroechinasteroside A, desulfated Echinasteroside B, Linckoside B, 
Linckoside E, Linckoside F, Laeviuscoloside D, Granulatoside A, Steroid Heptaol 
Culcita 
novaeguineae 
Asterosaponins: Novaeguinosides I and II, Regularoside B 
Asterosaponin 1, Asterosaponin 2, Asterosaponin 3, Novaeguinosides A–D, Novaeguinoside E 
Polyhydroxy steroidal glycosides: Culcinosides A–D, Linckoside B, Halityloside A, Halityloside B, 
Culcitoside C5, Halityloside D, Halityloside E, Echinasteroside C, Linckoside F, Linckoside L 
Pentaceraster 
gracilis 
Pentacerosides A and B 
Nodososide 
(5α,25S)-cholestane-3β,6α,815β,16β,26-hexol 3-O-[(2-O-methyl)-β-D-xylopyranoside] 
Maculatoside 
Protoreasteroside 
2. Acanthaster planci (Valvatida: Acanthasteridae) 
The starfish Acanthaster planci (Linnaeus, 1758) (Figure 1) lives in tropical waters of the Indian 
and Pacific Oceans. It is one of the largest starfishes, also known as “crown of thorns” because its 
body possesses numerous large, venomous spines [18]. Its colour varies from red and orange to 
purple and is thought that these variations could be the result of differences in diet. 
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Figure 1. Acanthaster planci [19]. © Craig Howe (CC BY-NC-ND)  
The crude extract of A. planci was tested against human breast cancer MCF-7 cell line by Mutee 
et al. [20]. The study demonstrated that the extract has potent cytotoxic as well as apoptotic effects 
on human breast cancer MCF-7 cell lines compared to tamoxifen. Thus, the results suggested that the 
extract of A. planci starfish, given its strong cytotoxic effect, could be employed as a chemotherapeutic 
agent in the treatment of breast cancer. Lee et al. [21] in their study extracted a protein toxin from 
venom of the crown-of-thorns starfish Acanthaster planci (Crown-of-thorns Acanthaster planci Venom, 
CAV), the structure of which was identified as plancitoxin protein. The cytotoxic activity against five 
cell lines was investigated and the results showed that CAV has an anti-proliferative effect on all cell 
lines, but in particular on human malignant melanoma A375.S2 cells. Investigations about the 
mechanism of action suggested that CAV reduce cell viability by inducing apoptotic events, which 
are mediated by mitochondrial membrane and p38 pathways. Moreover, plancitoxin I inhibits the 
proliferation of A375.S2 cells by inducing oxidative stress, mitochondrial dysfunction and 
Endoplasmic Reticulum stress-associated apoptosis [22]. 
Four different fraction of A. planci extract (ethanol, non-polar, ethylacetate and butanol fractions) 
were used to investigate their antioxidant and anticancer properties. Among them, the ethanol 
fraction showed the highest antioxidant effect, while the butanol fraction induced a significant 
proliferation inhibition in human malignant melanoma A375.S2 cells. Moreover, further analysis 
demonstrated that butanol fraction induces both apoptosis and necrosis in A375.S2 cells, evidenced 
by the upregulation of caspase-3 activity compared to the control and by a significant increase of 
inter-nucleosomal DNA fragmentation. Thus, A. planci can be considered as an important source of 
biologically-active substances with relevant antioxidant and anticancer effects [23]. 
New steroid biglycosides, named plancisides A, B, and C were isolated from the ethanolic extract 
of A. planci [18]. Plancisides A exhibited a slight inhibition of cell proliferation of three cancer cell 
lines (HCT-116, T-47D, and RPMI-7951), but had no relevant effects on colony formation. More 
recently, the biological activity of a new asterosaponin, called acanthaglycoside G, was investigated 
along with that of three already known steroidal oligoglycosides (Pentareguloside G, 
Acanthaglycoside A, Maculatoside) from A. planci [24]. An 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) assay showed that 
Acanthaglycoside G and Pentareguloside G exert a negligible cytotoxic effect against human 
melanoma RPMI-7951, human colorectal carcinoma HT-29, and human breast adenocarcinoma 
MDA-MB-231 cell lines, while Acanthaglycoside A and Maculatoside slightly inhibited cell viability 
of HT-29 and MDA-MB-231 cell lines. However, the same compounds exhibited an effective 
inhibition of the colony formation of cell lines and the ability to prevent the migration of MDA-MB-
231 cells, known to have a high metastatic potential. 
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3. Anthenea (Valvatida: Oreasteridae) 
Anthenea chinensis (Gray, 1840) is an abundant starfish distributed in South China Sea and East 
China Sea. Ma and collaborators [25] isolated a peculiar polyhydroxysteroidal glycoside, named 
Anthenoside A, from the starfish A. chinensis. It exhibited a potent cytotoxic activity against human 
leukemia K-562, hepatoma BEL-7402 and glioblastoma U87MG cells, beside the tubulin 
polymerization-promoting activity. A later study [26] led to the isolation of ten new 
polyhydroxysteroidal glycosides from the same starfish A. chinensis. The extracted compounds, 
called Anthenosides B–K, were tested against three human tumor cell lines. Most of them showed an 
inhibitory activity against human leukemia K-562 and human hepatoma BEL-7402 cell lines. 
Furthermore, the mixture of two compounds exhibited also cytotoxicity against human 
spongioblastoma U87MG cell line and promoted tubulin polymerization. 
In recent years another research group isolated six polyhydroxysteroidal glycosides 
(anthenosides S1–S6) from the methanolic extract of the starfish Anthenea sibogae (Döderlein, 1915). 
The cytotoxic assay showed a slight inhibition of the proliferation of human breast cancer T-47D cell 
line by the mixture of two extracted compounds [27]. 
In a further study [14] the isolation of new steroidal glycosides from the starfish Anthenea aspera 
(Döderlein, 1915) was carried out (Figure 2), and their in vitro effects on colony formation, cell 
viability, and apoptosis promotion in three different types of human tumor cell lines, i.e., human 
melanoma RPMI-7951, breast adenocarcinoma T-47D and colorectal carcinoma HT-29, were 
evaluated. All the tested compounds showed inhibitory effect on colony formation at nontoxic 
concentration in the three cell lines. Furthermore, the mixture of two molecules (anthenosides J and 
K) showed a significant anticancer effect through the induction of apoptosis. Indeed, these 
compounds cause the downregulation of anti-apoptotic protein expression (Bcl-XL) and the up-
regulation of the pro-apoptotic protein expression (Bax and Bak), leading to the activation of the 
initiator caspase-9 and, in turn, of the effector caspase-3. 
 
Figure 2. Anthenea aspera [28]. 
Furthermore, two polyhydroxysteroidal glycosides, anthenosides A1 and A2, along with the 
known anthenoside A, were isolated from A. aspera. They contain a 2-acetamido-2-deoxy-4-O-methyl- 
β-D-glucopyranosyl residue, not previously found in the starfish steroidal glycosides. All the tested 
compounds exhibited a slight inhibition of cell viability of human cancer T-47D cells, while lacking 
cytotoxicity against RPMI-7951 cells. Moreover, Anthenosides A1 inhibited colony formation of 
RPMI-7951 cells moderately if compared to Anthenosides A2 that showed a reduction of the number 
of colonies of T-47D cells down to 40% [29]. 
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4. Archaster typicus (Valvatida: Archasteridae) 
Archaster typicus (Müller & Troschel, 1840) is distributed in the shallow waters of the Western 
Indian Ocean and the Indo-Pacific. Also known as a sand star, it has five long, slightly tapering arms 
with pointed tips [30]. It has usually a grey or brownish colour, variously marked with darker and 
lighter patches (Figure 3). 
 
Figure 3. Archaster typicus [31]. © budak. Some rights reserved (CC-BY-NC)  
Kicha et al. [32] isolated new asterosaponins, named Archasterosides A and B, and the known 
regularoside A from the starfish A. typicus and their anticancer properties were evaluated. The 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) MTS assay 
revealed that all three compounds display a moderate anticancer activity and cytotoxicity against 
human cancer HeLa cells and mouse epidermal JB6 P + Cl41 cells, even if with different IC50. 
Moreover, since Archasterosides B exhibited the highest restraining potential compared to the other 
two tested compounds, further analyses were performed to investigate its effect on the basal AP-1-, 
p53, and NF-κB-dependent transcriptional activities, using JB6 Cl41 cells. The result showed for the 
first time that Archasterosides B induced basal p53- and AP-1-, but not NF-κB-dependent 
transcriptional activities compared to untreated controls. 
5. Asterias amurensis (Forcipulatida: Asteriidae) 
Asterias amurensis (Lutken, 1871) is commonly known as Northern Pacific sea star or Japanese 
sea star (Figure 4). It is widely distributed in estuarine, intertidal, and coastal zones of the Pacific 
Ocean near Japan, Russia, Northern China, and Korea, but this species habits also the southern 
Australian coast (especially Tasmania), Alaska and the Aleutian Islands, Europe, and the state of 
Maine. A. amurensis has five arms, which joins in the center of the animal forming a central disc. 
Below each arm run irregularly arranged spines. They also line the ventral groove of each arm, where 
the tube feet are found. This starfish is characterized by a variety of colours, ranging from orange to 
yellow, or sometimes purple on their dorsal side [33]. 
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Figure 4. Asterias amurensis [34]. 
Lei et al. [35] examined the anti-tumor activity of cerebrosides derived from the sea cucumber 
Acaudina molpadioides (AMC) and the starfish Asterias amurensis (AAC), both in vitro and in vivo. 
Cerebrosides are one of the simplest classes of glycosphingolipids that are widely present in the 
plasma membranes of fungi, plants and marine organism. They are characterized by 
monosaccharides, an amide-linked fatty acid and a sphingoid base commonly named long-chain base 
[36] and in several studies they showed to play a series of biological roles [37–39]. In particular, these 
molecules were tested in vitro against murine sarcoma cells (S180) and the results obtained 
demonstrated a dose-dependent inhibitory effect of AAC-derived cerebrosides on cell proliferation, 
which appears stronger and more efficient than that of AMC-derived ones. Further investigations 
revealed that this restraining effect occurs through the mitochondria-mediated apoptosis pathway, 
via the downregulation of Bcl-2 and Bcl-XL expression and the up-regulation of Bax, Cytochrome c, 
caspase-9 and caspase-3 expression. In addition, a significant reduction of tumor growth was 
obtained in vivo by treating S180 tumor-bearing mice, although in this case AAC-derived 
cerebrosides were less potent than AMC-derived ones. 
6. Asterina pectinifera (Valvatida: Asterinidae) 
Asterina pectinifera (Muller & Troschel, 1842), also known as blue bat starfish, is native to the 
Yellow Sea, Sea of Japan and Est Sea but it habits also the coasts of Russia. It has five large and short 
arms and presents a vivid color (blue) with some orange spots (Figure 5). Usually A. pectinifera prefers 
the shallow zones of the sea and feeds on small invertebrates, algae, and detritus. 
 
Figure 5. Asterina pectinifera [40]. © Alexander Semenov. 
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Lou et al. [41] in their study tested the biological activity of a series of peptides derived from the 
motifs of cyclin B of A. pectinifera. Interestingly, the complex CDK1/cyclin B of this starfish, described 
by McGrath [42], showed a significant similarity with the human CDK2/cyclin A complex. Therefore, 
the authors investigated the biological potential of three selected motifs of cyclin B (α5 helix, α3 helix 
and N-terminal, named a5, a3 and N respectively) on two human tumor cell lines, i.e., HCT-116 
(human colon adenocarcinoma cells) and EC-9706 (esophageal carcinoma cells). To facilitate the 
cellular uptake of these peptides, they were conjugated with the protein transduction domain of HIV-
1 transactivator of transcription (Tat). The results showed a significant cytotoxic activity of Tat-a5 in 
both cell lines, compared to the other peptides examined. Further investigations suggested that Tat-
a5 compete with Cyclin B1 and bind to CDK1 preventing its excessive activation. As a consequence, 
cancer cells get arrested at G2/M phase and go toward apoptosis. These considerations suggest that 
the peptide Tat-a5 could be a novel relevant compound with anticancer and tumor angiogenesis-
inhibiting activity. 
Peng and his collaborators [43] isolated a new polyhydroxysterol ester and seven known steroid 
derivatives from A. pectinifera. They investigated the cytotoxic potential of these molecules and the 
results showed that only two compounds (25S)-5α-cholestane-3β,4β,6α,7α,8,15β,16β,26-octol and 
Cholest-7-en-3-sodium sulfate had a marginal antitumor activity on human liver carcinoma HepG2 
cells in vitro. 
Malyarenko et al. [44] recently investigated the anticancer and radiosensitizing activities of polar 
steroids from A. pectinifera in human colorectal carcinoma cells DLD-1, HCT 116, and HT-29. Among 
the tested compounds, (25S)-5α-cholestane-3β,4β,6α,7α,8,15β,16β,26-octaol and Asterosaponin P1 
showed the greatest results in terms of cytotoxic activity. Moreover, Asterosaponin P1 strengthened 
the efficacy of radiation, leading to the reduction of the number and size of the colonies of colorectal 
cancer cells. Further experiments demonstrated that the radiosensitizing activity of this compound is 
given by apoptosis induction via the regulation of anti- and pro-apoptotic protein expression 
followed by the activation of the initiator and effector caspases (caspase-9 and caspase-3, 
respectively) and DNA degradation. 
Another interesting study of Nam and Shon [45] investigated the effect of polysaccharides 
extracted from A. pectinifera. In a previous study [46] it was demonstrated that polysaccharides 
extracted from A. pectinifera inhibited the cytochrome P450 1A1- mediated ethoxyresorufin O-
deethylase activity and reduced significantly the ornithine decarboxylase activity in polysaccharide-
treated MCF-7 breast cancer cells. Then, the activity of phase II detoxification enzymes, such as 
quinone reductase (QR), glutathione S-transferase (GST) and ornithine decarboxylase (ODC) in HT-
29 human colon adenocarcinoma cells was investigated [45]. These enzymes are involved in the 
prevention of carcinogen-induced colon cancer. The results showed that the polysaccharides 
increased the activity of both QR and GST enzymes. This suggests the presence of some constituents 
capable to prevent the initiation of colon carcinogenesis through this mechanism. Moreover, the 
treatment of the HT-29 cells with the polysaccharides extracted from A. pectinifera showed a reduced 
activity of ODC, whose induction stimulate tumor promotion. Further investigations showed the 
inhibition of TPA-induced COX-2 activity, suggesting a useful application of these polysaccharides 
in the inhibition of colon carcinogenesis. 
The chemopreventive effect of this type of extract was also demonstrated by Lee et al. [47]. They 
investigated the biological activity of A. pectinifera polysaccharides on the progression and metastasis 
of human breast cancer. The results showed for the first time the ability of starfish polysaccharides to 
suppress carcinogenesis and dissemination of human breast cancer through the decrease of COX-2 
and aromatase expression and the inhibition of cell motility. Thus, these promising results suggest 
that starfish polysaccharides might be valuable chemopreventive agents. 
 Moreover, Kim and collaborators in another recent study [48] demonstrated that the A. pectinifera 
fermented with C. militaris mushroom mycelia (FACM) displayed a strong anti-cancer activity, 
compared to unfermented A. pectinifera. Indeed, FACM was able to decrease B16F10 murine 
melanoma cell proliferation significantly, increasing in parallel the activation of apoptosis by 
increasing levels of the pro-apoptotic protein Bax and reducing the levels of the anti-apoptotic protein 
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Bcl-2. This means that FACM could be a promising anti-cancer agent, but further studies are needed 
to identify the bioactive substances responsible of these biological effects. 
7. Asteropsis carinifera (Valvatida: Asteropseidae) 
The starfish Asteropsis carinifera (Lamarck, 1816) is distributed in the Indo-Pacific area. It has five 
arms characterized by the presence of large conical and dull spines aligned in the middle and on the 
periphery of each arm. The body is relatively flat but slightly convex towards the middle of the central 
disk and the colour is usually gray with stained brown spots (Figure 6). 
 
Figure 6. Asteropsis carinifera [49]. © P. Bourjon. 
Six steroidal biglycosides, named Cariniferosides A–F, along with six previously known 
glycosides, were isolated from the alcoholic extract of the starfish A. carinifera in a study of 
Malyarenko et al. [50]. The isolated compounds were evaluated for their biological activities on 
human breast cancer cells T-47D, human malignant melanoma cells RPMI-7951, and human colon 
cancer cells HCT-116. The results did not show cytotoxicity in any of the cancer cell lines tested. 
However, three compounds, compared to the others, significantly inhibited colony formation of 
RPMI-7951 and T-47D cell. Subsequently, a new asterosaponin, Asteropsiside A, was isolated from 
the starfish A. carinifera and the biological effect of two previously known asterosaponins, 
Regularoside A and Thornasteroside A were evaluated [51]. The cytotoxicity assays demonstrated 
that both glycosides exhibit toxic properties against HCT-116, RPMI-7951, and T-47D cancer cell lines. 
Moreover, a clonogenic assay showed also the ability to inhibit the rate of colony formation of tumor 
cells in vitro. 
8. Astropecten (Paxillosida: Astropectinidae) 
The genus Astropecten includes a huge amount of species, very similar to each other, that inhabit 
sandy or muddy seabeds. One of them, Astropecten polyacanthus (Müller & Troschel, 1842) is 
commonly known as the Sand Sifting Starfish (Figure 7). It is an innocuous invertebrate, distributed 
in the Indo-Pacific Ocean. It possesses teeth or spine like structures running along the outer edges of 
its five arms, which help the sea star to conduct its benthic life, by moving, burrowing, and feeding. 
Mar. Drugs 2019, 17, 617 11 of 29 
 
 
Figure 7. Astropecten polyacanthus [52]. © Chaloklum Diving CC-BY-3.0 
(https://commons.wikimedia.org). 
Thao et al. [53] in their study isolated four steroids, called Astropectenols A-D, along with three 
known compounds (5-7) from A. polyacanthus. They evaluated the anti-cancer activity of the methanol 
extract and of the isolated compounds on three human cancer cell lines, HL-60 (leukemia cells), PC-
3 (prostate cancer cells) and SNU-C5 (colorectal cancer cells). The extract of the starfish showed a 
potent cytotoxic activity against leukemia cells and prostate cancer cells, while only the compound 7 
exhibited a relevant cytotoxicity compared to the others. Further investigations suggested that the 
inhibitory activity is due to the induction of apoptosis, mediated by the regulation of apoptosis-
related protein expression (i. e. down-regulation of Bcl-2, up-regulation of Bax, cleavage of caspases-
9, caspases-3 and PARP) and via the downregulation of ERK1/2 pathway and of the oncoprotein C-
myc. 
A recent study of Vien [54] investigated the cytotoxicity of five polar steroid derivatives, 
including one new glycosylated polyhydroxysteroid named polyacanthoside, isolated from the 
water-soluble materials from the MeOH extract of A. polyacanthus. Only (20R,24S)-3β,6α,8,15β,24-
pentahydroxy-5α-cholestane exhibited significant cytotoxic effect against five human cancer cell lines 
as HepG2 (hepatoma cancer), KB (epidermoid carcinoma), LNCaP (prostate cancer), MCF7 (breast 
cancer), and SK-Mel2 (melanoma). The compounds Marthasteroside B and Psilasteroside had 
moderate effects on all five cell lines, whereas Polyacanthoside A and Triseramide appeared to 
display an even lesser activity. 
The starfish Astropecten monacanthus (Sladen, 1883) (Figure 8) habits the benthic tropical zone of 
the Indo-Pacific Ocean. 
 
Figure 8. Astropecten monacanthus [55]. 
Mar. Drugs 2019, 17, 617 12 of 29 
 
Thao et al. [56] in their study isolated six asterosaponins from A. monacanthus, whose structure 
and anti-inflammatory activity were elucidated in a previous work [57]. Both the whole extract and 
the isolated compounds were tested against three human cancer cell lines (HL-60, PC-3, SNU-C5) to 
check their cytotoxic potential. The results showed a potent cytotoxic activity of Astrosterioside D on 
all cell lines. Furthermore, the methanol extract exhibited a more potent cytotoxic activity compared 
to the isolated saponins. This suggested that the inhibitory activity could be due to the synergic effect 
of more than one compound. Further investigations clarified that the induction of apoptosis through 
the downregulation of PI3K/AKT and ERK 1/2 MAPK pathways is responsible of the cytotoxic 
activity. 
9. Certonardoa semiregularis (Valvatida: Ophidiasteridae) 
Certonardoa semiregularis (Muller & Troschel, 1842) is widely diffused in the Eastern China Sea 
and Japan. It has five slender arms broad at base, cylindrical in cross-section, and tapering to rounded 
tips. The dorsal surface is usually red and characterized by plates that are organized in regular 
longitudinal and transverse rows, while the ventral surface is pale [58]. 
Wang and his group [59], isolated a series of biomolecules from C. semiregularis and tested their 
cytotoxic activity against a panel of human solid tumor cell lines (A549, SK-OV-3, SK-MEL-2, XF498, 
HCT15). The polyhydroxysterols, named Certonardosterols, showed moderate to significant 
cytotoxicity against these cell lines. Four new saponins, designated as Certonardosides K – N, were 
evaluated for their cytotoxic activities along with the previous extracted compounds, 
Certonardosides A–J [60,61]. Among them, certonardoside C was the most active against the SK-
MEL-2 skin cancer cell line. Further studies [62,63] led to the isolation of a significant number of new 
polyhydroxysterols and ten new saponins, which showed again a considerable cytotoxic activity 
against a series of human tumor cell lines. In particular, a rare example of 15-keto steroid exerted the 
highest cytotoxic effect. Moreover, two new sulfated saponins, Certonardosides P2 and I3, were 
isolated from the brine shrimp active fraction of the methanolic extract of C. semiregularis. These 
compounds were tested for their cytotoxic potential against five human tumor cell lines (A549, SK-
OV-3, SK-MEL-2, XF498, and HCT15), but only Certonardosides P2 displayed a relevant cytotoxicity 
against the SK-MEL-2 skin cancer cell [58]. 
10. Choriaster granulatus (Valvatida: Oreasteridae) 
Choriaster granulatus (Lütken, 1869) habits the Indo-West Pacific waters (Figure 9). It is found in 
sandy zones, among corals and sponges and feeds on coral polyps and other small invertebrates. This 
starfish has a large convex body with five short arms. It has a typical pale pink color characterized by 
brown papillae in the center. 
 
Figure 9. Choriaster granulatus [64]. © Mark & Marta Bockstael-Rubio  
(https://www.jungledragon.com). 
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Recently, Ivanchina et al. [65] by continuing their research about C. granulatus, isolated sixteen 
polar steroids, along with two new polyhydroxy glycosides, granulatosides D and E, from the 
ethanolic extract of the starfish. The investigations on the cytotoxic potential of these compounds 
demonstrated that only four of the tested compounds (Granulatosides D, Echinasterosides F, 
desulfated Echinasteroside B and Laeviuscoloside D) exhibited a significant cytotoxic activity against 
murine splenocytes. 
11. Craspidaster hesperus (Paxillosida: Astropectinidae) 
Craspidaster hesperus (Muller & Troschel, 1840) (Figure 10) is distributed in the Indo-West Pacific 
Ocean. It is a flat sea star with five elegant tapered arms. The dorsal surface of its body presents 
special flat-topped, pillar-like structures, called paxillae. Large marginal plates characterize the 
body’s edges and the tube feet are pointed [66]. 
 
Figure 10. Craspidaster Hesperus [67]. (c) budak, Some Right Reserved (CC BY-NC) 
Kang et al. [15] isolated three polyhydroxysteroidal glycosides (hesperuside 1–3) from the 
starfish Craspidaster hesperus. These compounds exhibited cytotoxic activity against three types of 
human cancer cells (human leukemia MOLT-4, human hepatoma BEL-7402 and human lung cancer 
A-549). Interestingly, it was supposed a possible correlation between the cytotoxicity and the 
structural features of the steroidal glycosides. 
12. Ctenodiscus crispatus (Paxillosida: Ctenodiscidae) 
The starfish Ctenodiscus crispatus (Bruzelius, 1805) (Figure 11) is broadly distributed worldwide, 
especially on mud bottoms of northern coasts [68]. It has rounded short and large arms, the dorsal 
side is large, usually yellow-orange, while the ventral side is whitish. This starfish is characterized 
by the presence of vertical row of spikes and cilia along the edge of arms that form the so-called 
cribriform organ. This helps to increase the flow of oxygen rich water across the body when it is 
covered in the mud where the starfish live. 
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Figure 11. Ctenodiscus crispatus [69]. © Rick (https://www.flickr.com). 
Quang and collaborators [70] isolated and identified five steroids from C. crispatus and 
investigated the biological potential of these compounds on two cell lines from human hepatocellular 
carcinoma (HepG2) and human glioblastoma (U87MG). Among the five, only one of these 
compounds, the (25S)-5α-cholestane-3β,5,6β,15α,16β,26-hexaol, showed relevant biological activity. 
It exhibited a clear reduction in cell viability of both cell lines in a dose-dependent manner. The 
following investigations performed to elucidate the mechanism responsible of cell death suggested 
that the cytotoxic effect of this compound could be derived from the induction of apoptosis, through 
an up-regulation of the ratio of Bax:Bcl-2, followed by the release of cytochrome c from the 
mitochondria and the associated activation of caspases and PARP. 
13. Culcita novaeguineae (Valvatida: Oreasteridae) 
Culcita novaeguineae (Müller & Troschel, 1842), commonly known as pin cushion star, is 
pentagonal in shape, with short arms and an inflated appearance (Figure 12). The ventral side 
presents a central mouth and rows of tube feet. C. novaeguineae is characterized by variable colours, 
and it usually habits the coral reefs of the warm water in the Indo-Pacific Ocean. 
 
Figure 12. Culcita novaeguineae [71]. © Western Australian Museum Collections (CC BY 4.0). 
Mar. Drugs 2019, 17, 617 15 of 29 
 
Two asterosaponins, named novaeguinosides I and II, together with a known saponin, 
regularoside B, were isolated from the starfish Culcita novaeguineae [72]. The cytotoxic activity of these 
compounds was tested, and the results showed a marginal effect against two human tumor cell lines 
(human leukemia K-562 cells and human hepatoma BEL-7402 cells). 
Zhou and collaborators [73] in their study investigated the biological activity of novaeguinoside 
II on human U87MG glioblastoma cell line. This compound showed a relevant suppression of 
U87MG cell proliferation due to the activation of mitochondrial apoptotic pathway, characterized by 
the up-regulation of cytochrome-c and caspase-3 expression. Another study [74] led to the isolation 
of novel asterosaponins. Among them, Asterosaponin 1 and 3 showed a significant cytotoxic activity 
against two human tumor cell lines, i.e., leukemia K-562 and hepatoma BEL-7402. 
Subsequently, Asterosaponin 1 was proven capable to inhibit the growth of human glioblastoma 
cells through the mechanism of apoptosis, in a dose- and time-dependent manner [75]. These findings 
suggest the employment of Asterosaponin 1 as a promising novel anticancer drug. Some years later, 
four novel asterosaponins, named novaeguinosides A-D, were isolated from C. novaeguineae and 
demonstrated the capability of promoting the polymerization of tubulin in vitro [76]. Moreover, the 
evaluation of the in vitro cytotoxic activity of these new asterosaponins showed great results against 
K-562 and BEL-7402 cells. Two asterosaponins, including a new compound named Novaeguinoside 
E, and six glycosylated polyhydroxysteroids were isolated from a methanol extract of the starfish C. 
novaeguineae [77]. The investigation about their biological activity against five human cancer cell lines 
demonstrated that halytilosided B and D have a moderate cytotoxic activity against KB (epidermoid 
carcinoma), LNCaP (prostate cancer), MCF7 (breast cancer), and SK-Mel2 (melanoma); halytiloside 
A showed a moderate cytotoxicity against LNCaP and MCF7 cells, but a weaker effect on KB and SK-
Mel2 cells. Culcitoside 5 exhibited a weak cytotoxic activity against KB, LNCaP, MCF7 and SK-Mel2 
cell lines. Recently, the cytotoxic activity of new polyhydroxy steroidal glycosides, named 
culcinosides A-D, against human glioblastoma cell lines was evaluated [78]. Among them, 
culcunoside A showed a significant activity, while the others demonstrated a moderate cytotoxicity. 
14. Echinaster luzonicus (Spinulosida: Echinasteridae) 
The starfish Echinaster luzonicus (Gray, 1840) populates the tropical and sub-tropical western 
Indo-Pacific area. It has six thin arms and its colour range from red and brown, according to the 
surrounding environment in which they live (Figure 13). 
 
Figure 13. Echinaster luzonicus [79]. © Bernard Dupont (CC-BY-SA-2.0). 
In recent years, Malyarenko [80] tested two cyclic steroidal glycosides, Luzonicoside A (LuzA) 
and D (LuzD) extracted from the starfish E. luzonicus, against human RPMI-7951 and SK-MEL-28 
Mar. Drugs 2019, 17, 617 16 of 29 
 
melanoma cells. The in vitro inhibitory activity of these molecules and their mechanism of action 
were investigated. The results showed a significant anti-cancer activity induced by cell cycle 
regulation and apoptosis; in particular, the up-regulation of p21 and the downregulation of the 
expressional levels of Cyclin D1 lead to cell cycle arrest, while the downregulation of Bcl-2 protein 
and the activation of the effector caspase-3 determine the apoptotic event. Moreover, LuzA revealed 
a major capability of inhibiting the proliferation, the migration and the formation of colonies of cancer 
cells compared to LuzD. However, the overall results suggest a promising development of both LuzA 
and D as anti-cancer drugs. 
15. Henricia leviuscula (Spinulosida: Echinasteridae) 
Henricia leviuscula (Stimpson, 1857), commonly known as the Pacific blood star, is a starfish that 
habits the Pacific coast of North America. It has a brilliant red-orange color and five, long, tapering 
arms, characterized by the absence of pedicellariae and spines (Figure 14). 
 
Figure 14. Henricia leviuscula [81]. © Christopher Lindsey  
An interesting study of Fedorov [82] reports the evaluation of the proapoptotic and 
anticarcinogenic properties of Leviusculoside G, a glycosylated steroid isolated from H. leviuscula. 
The results revealed that the treatment of human leukemia HL-60, THP-1, and mouse skin JB6 Cl41 
cells with nontoxic doses of Leviusculoside G induced apoptosis and decreased cell transformation. 
Moreover, preliminary studies aimed to clarify the mechanism of action of this compound 
demonstrated that Leviusculoside G could exert its effect through the promotion of p53-dependent 
apoptosis and the inhibition of AP-1, NF-κB, and ERK activities. 
16. Hippasteria phrygiana (Valvatida: Goniasteridae) 
Hippasteria represents a group of cold-water starfishes, typically coral/cnidarian predators. They 
are five-armed sea stars, characterized by a large and flattened central disc. Hippasteria phrygiana 
(Parelius, 1768 from World Register of Marine Species-WoRMS), also named H. kurilensis, is widely 
distributed in the oceans (Figure 15). 
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Figure 15. Hippasteria phrygiana [83]. (c) Viktor V. Grøtan, some right reserved (CC BY-NC),  
Kicha et al. [84] isolated four new asterosaponins, Hippasteriosides A–D, from the alcoholic 
extract of the Far Eastern starfish H. kurilensis. The structures of the compounds were characterized 
and their cytotoxic activity was evaluated against human colon tumor HT-29 cells. All the 
compounds did not show a significant effect on cell growth within a 15–120 mg·ml−1 concentration 
range. However, Hippasterioside D at non-cytotoxic concentration (60 mg·ml−1) was able to reduce 
both colony number and size if compared with non-treated cells, while Hippasteriosides A and B 
exhibited a less pronounced potential than hippasterioside D in inhibiting cell transformation. 
Hippasterioside C failed to demonstrate any significant effect on HT-29 cells. Thus, Hippasterioside 
D seems promising for further investigation as an anticancer agent. 
Another study [85] led to the isolation of the new cyclopropane-containing steroid Phrygiasterol 
from the ethanol extract of H. phrygiana. It was tested against Ehrlich carcinoma cells, together with 
another component of the extract called Borealoside C to investigate their biological activity. The 
results showed a moderate cytotoxic activity of Phrygiasterol against Ehrlich carcinoma cells, while 
Borealoside induced apoptosis of the same cell line. 
17. Leptasterias ochotensis (Forcipulatida: Asteriidae) 
Leptasterias ochotensis (Brandt, 1851) belongs to the genus Leptasterias, whose members are 
characterised by having six arms. 
Malyarenko et al. [86] investigated the biological activity of the asterosaponins leptasteriosides 
A–F, one new and one previously known asterogenin, extracted from the starfish Leptasterias 
ochotensis. The compounds exhibited different effects. Only the three asterosaponins Leptasterioside 
B, Leptasterioside C, and particularly Leptasterioside A showed a significant cytotoxic activity 
against T-47D cell line. Moreover, Leptasterioside A exhibited also the highest inhibitory effect on 
colony formation by T-47D breast cancer cell line at low concentration compared to the others. 
Interestingly, the effects of the compounds on colony formation was also dependent on the type of 
cell line. Moreover, Leptasterioside A at low concentration was shown to be more effective in 
inhibition of colony formation of T-47D and RPMI-7951 cells than cisplatin, used as positive control 
by the authors. Therefore, the overall results indicated that Leptasterioside A could be a promising 
cancer-preventive and anticancer agent, but further investigations are needed to confirm this 
hypothesis. 
Another study [87] reported the isolation of three new sulfated steroid monoglycosides, called 
leptaochotensosides A–C, and a new sulfated polyhydroxylated steroid from L. ochotensis. The 
cytotoxicity of the compounds against melanoma RPMI-7951 and breast cancer T-47D cell lines was 
investigated, but in both cases the molecules were not found able to decrease cell viability. Then, the 
effect of the compounds on colony formation of human melanoma RPMI-7951 and human breast 
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cancer T-47D cells was also checked. Interestingly, only Leptaochotensoside A reduced the colony 
formation of T-47D cells in a significant way compared with non-treated controls. In order to better 
understand the mechanism of action of the molecule, the mouse epidermal JB6 Cl41 cells were used 
to test the effect of Leptaochotensoside A on EGF-induced colony formation. The results showed a 
relevant reduction of colony and this cancer preventive action of leptaochotensoside A appeared to 
be associated with the regulation of mitogen-activated protein kinase (MAPK) signalling pathway (i. 
e. ERK1/2 and MSK-1 kinases). 
18. Lethasterias fusca (Forcipulatida: Asteriidae) 
Two new asterosaponins, lethasteriosides A and B, along with previously known glycosides, 
thornasteroside A, anasteroside A and luidiaquinoside were extracted from Lethasterias fusca 
(Djakonov, 1931) by Ivanchina et al. [88]. The cytotoxicity against human breast T-47D, colorectal 
carcinoma HCT-116, and melanoma RPMI-7951 cancer cell lines was evaluated. The tested 
compounds did not show significant cytotoxic effect against these cancer cell lines. Anyway, 
lethasteriosides A, exhibited an interesting inhibition of the colony formation in all the cell lines. 
19. Narcissia canariensis (Valvatida: Ophidiasteridae) 
Narcissia canariensis (d’Orbigny, 1839) is a five-armed starfish characterized by an even orange 
colour with a yellow tip at the end of each arm (Figure 16). This species is widely distributed in the 
Canaries, but it also inhabits the areas of Cape Verde, the Gulf of Mexico, Madeira, the Azores and 
the Congo. 
 
Figure 16. Narcissia canariensis [89]  
The glycolipid fraction isolated from the starfish N. canariensis, containing particular 
glycosphingolipids named ophidiacerebrosides, was evaluated for its cytotoxic activity against 
various human cancer cell lines from multiple myeloma, colorectal adenocarcinoma and 
glioblastoma multiforme by Farokhi [90]. The results demonstrated that the fraction (F13-3) displayed 
an interesting cytotoxic activity over 24 h. 
20. Pentaceraster gracilis (Valvatida: Oreasteridae) 
The starfish Pentaceraster gracilis (Lütken, 1871) habits the bays of North Australia and the waters 
of Indian Ocean and Red Sea. It has a peculiar short triangular form from which the long arms depart. 
The study of Vien et al. [91] reports the isolation of two steroid glycosides namely Pentacerosides A 
and B, and four know compounds from the methanol extract of the starfish P. gracilis. The cytotoxic 
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activity of the isolated compounds against five human cancer cell lines, HepG2 (hepatoma cancer), 
KB (epidermoid carcinoma), LNCaP (prostate cancer), MCF7 (breast cancer), and SK-Mel2 
(melanoma) was investigated. Only maculatoside displayed a significant cytotoxic effect against 
Hep-G2 and SK-Mel2 cell lines and a moderate effect on KB, LNCaP and MCF7 cell lines, compared 
to the positive control, ellipticine. 
21. Focusing on cytotoxic potential and the mechanism of action 
Starfish-derived steroidal glycosides represent an interesting and promising resource for the 
treatment of cancer. Indeed, the multitude of studies performed during the recent years highlighted 
the important biological potential of these secondary metabolites extracted from a variety of starfish 
species. Among them, as already mentioned, polyhydroxysteroidal glycosides and asterosaponins 
showed the more prominent cytotoxic effect and anti-tumor activity against a great deal of human 
cancer cell lines. A summary of the most efficient compounds and their biological effects is reported 
in Tables 2 and 3. 
Table 2. Steroidal glycosides that exhibit the highest anticancer activity against various tumor cell 
lines. 
Compounds Species Tumor Cell Lines Mechanism of 
Action 
IC50 
Crude extract Acanthaster 
planci 
Human breast cancer 
MCF-7 cell lines 
Induction of 
apoptosis 
15.6 µg·mL−1 
Plancitoxin I  A375.S2 melanoma cells 
Inhibition of cell 
growth, 
induction of 
apoptosis 
mediated by 
mitochondrial 
membrane and 
p38 pathway 
5.67 µg·mL−1 
Butanol fraction  A375.S2 
Induction of 
apoptosis and 
necrosis 
112.65 µg·mL−1 
Anthenoside A 
Anthenea 
chinensis 
human leukemia K-562, 
hepatoma BEL-7402, 
glioblastoma U87MG 
cells 
 
-  
Anthenosides B–K  K-562, BEL-7402 cells -  
Anthenosides J–K Anthenea aspera 
human melanoma 
RPMI-7951, breast 
adenocarcinoma T-47D, 
colorectal carcinoma 
HT-29 
Induction of 
apoptosis 
89, 91, and 85 µM 
Archasterosides A 
Archaster 
typicus 
human cancer HeLa 
cells, mouse epidermal 
JB6 P+ Cl41 cells 
- 24 µM 
Archasterosides B  
human cancer HeLa 
cells, mouse epidermal 
JB6 P+ Cl41 cells 
Induction of p53- 
and AP-1-
dependent 
transcriptional 
activities 
14 µM 
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Regularoside A  
human cancer HeLa 
cells, mouse epidermal 
JB6 P+ Cl41 cells 
- 110 µM 
Methanol extract 
5α-cholest-7,9(11)-
diene-3β-ol 
Astropecten 
polyacanthus 
HL-60 leukemia cells, 
PC-3 prostate cancer 
cells 
Induction of 
apoptosis via 
regulation of 
apoptosis-related 
proteins and via 
the down-
regulation of 
ERK1/2 pathway 
and C-myc 
 
8.29 µg·mL−1 
25.42 µg·mL−1 
2.70 µM 
(20R,24S)-
3β,6α,8,15β,24-
pentahydroxy-5α-
cholestane 
 
HepG2 (hepatoma 
cancer), KB 
(epidermoid 
carcinoma), LNCaP 
(prostate cancer), MCF7 
(breast cancer), SK-
Mel2 (melanoma) 
 
- 18.03–21.59 µM 
Methanol extract 
Astrosterioside D 
Astropecten 
monacanthus 
HL-60, PC-3, SNU-C5 
colorectal cancer cells 
Induction of 
apoptosis via the 
inactivation of 
PI3K/AKT and 
ERK 1/2 MAPK 
pathways and 
down-regulation 
of C-myc 
0.84–3.96 µg·mL−1 
4.31–5.21 µg·mL−1 
Cerebrosides 
(AAC) 
Asterias 
amurensis 
murine sarcoma cells 
(S180) 
Induction of 
mitochondria-
mediated 
apoptosis 
216.36 µM 
Peptides derived 
from the motifs of 
cyclin B  
Asterina 
pectinifera 
HCT-116 human colon 
adenocarcinoma and 
EC-9706 esophageal 
carcinoma cells 
 
Induction of 
apoptosis 100 µM 
(25S)-5α-
cholestane-
3β,4β,6α,7α,8,15β,1
6β,26-octol 
Asterosaponin P1 
Cholest-7-en-3-
sodium sulfate 
 
HepG2,  
DLD-1, HCT 116, and 
HT-29 cells 
DLD-1, HCT 116, and 
HT-29 cells 
HepG2 
- 
- 
Radiosensitizing 
activity through 
apoptosis 
induction 
0.2 µM 
 
150 µM 
4 µM 
1.6 µM 
Fermented A. 
pectinifera with 
mushroom mycelia 
C. militaris (FACM) 
 
B16F10 murine 
melanoma cells 
Induction of 
apoptosis 
0.25–0.2 µg·mL−1 
Regularoside A 
Thornasteroside A 
Asteropsis 
carinifera 
T-47D human breast 
cancer, RPMI-7951 
human malignant 
- 
169, 117, 142 µM 
82, 35, 70 µM 
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melanoma, HCT-116 
human colon cancer 
cells  
Certonardosterols Certonardoa 
semiregularis 
A549, SK-OV-3, SK-
MEL-2, XF498, HCT15 
- - 
15-keto sterol  Unspecified - - 
Certonardoside C  SK-MEL-2  3.8 µg·mL−1 
Certonardosides L  
A549 SK-OV-3 SK-
MEL-2 XF498 HCT15 
- 
7.5, 6.8, 5.8, 6.4, 3.9 
µg·mL−1 
 
Certonardosides M  
A549 SK-OV-3 SK-
MEL-2 XF498 HCT15 - 
>30, >30, 9.7, 25.4, 
43.4 µg·mL−1 
 
Certonardosides N   
A549 SK-OV-3 SK-
MEL-2 XF498 HCT15 
- 
8.0, 8.4, 7.7, 7.2, 8.2 
µg·mL−1 
 
Certonardosides P2  SK-MEL-2  - - 
Granulatosides D, 
Echinasterosides F, 
desulfated 
Echinasteroside B 
Laeviuscoloside D 
Choriaster 
granulatus Murine splenocytes  - 
4.7 ± 1.2 
4.6 ± 0.3 
4.5 ± 0.4 
2.2 ± 0.3µM 
Hesperuside A Craspidaster 
hesperus 
leukemia MOLT-4, 
hepatoma BEL-7402  
human lung cancer A-
549 
- 
3.62 ± 1.08 
2.59 ± 0.94 
5.26 ± 0.36µM 
Hesperuside B  
leukemia MOLT-4, 
hepatoma BEL-7402  
human lung cancer A-
549 
- 
1.84 ± 0.65 
0.68 ± 0.12 
2.67 ± 0.54 
Hesperuside C  
leukemia MOLT-4, 
hepatoma BEL-7402  
human lung cancer A-
549 
- 
2.40 ± 0.73 
2.12 ± 0.81 
5.72 ± 0.82 µM 
(25S)-5α-
cholestane-
3β,5,6β,15α,16β,26-
hexaol 
 
Ctenodiscus 
crispatus 
HepG2, U87MG 
Inhibition of cell 
growth and 
induction of 
apoptosis 
10–200 µM 
Asterosaponin 1 Culcita 
novaeguineae 
U87MG cells Inhibition of cell 
growth 
4.3 µg·mL−1 
 
Asterosaponin 1 
Asterosaponin 3  K-562, BEL-7402 - 
3.57 µg·mL−1; 
2.55 µg·mL−1; 
3.75 µg·mL−1; 
1,89 µg·mL−1; 
Novaeguinosides A  K-562, BEL-7402 - 
3.0 ± 0.6, 2.4 ± 0.3 
µM 
Novaeguinosides B  K-562, BEL-7402 - 7.9 ± 1.5, 
9.5 ± 1.1 µM 
Novaeguinosides C  K-562, BEL-7402 - 1.3 ± 0.2 
0.7 ± 0.1µM 
Novaeguinosides D  K-562, BEL-7402 - 4.6 ± 0.5 
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4.1 ± 1.0µM 
Culcinoside A  
human glioblastoma 
cell lines (U87, U251, 
and SHG44) 
- 
9.35 ± 0.46 11.28 ± 
0.65 8.04 ± 0.32µM 
Phrygiasterol 
Hippasteria 
phrygiana 
 
Ehrlich carcinoma cells 
Inhibition of 
growth 
50 µg·mL−1 
Leptasterioside A 
Leptasterioside B 
Leptasterioside C  
Leptasterias 
ochotensis T-47D cells  - 
2 
10 
23 µM 
Ophidiacerebroside
s 
Narcissia 
canariensis 
KMS-11 multiple 
myeloma, 
HCT-116 colorectal 
adenocarcinoma  
GBM glioblastoma 
multiforme  
- ~ 20 µM 
Maculatoside Pentaceraster 
gracilis 
Hep-G2 
SK-Mel2 
- 16.75 ± 0.69µM 
19.44 ± 1.45µM 
Table 3. Other effects of biological active compounds from starfishes against human cancer cells. 
Compound Biological effect 
CAV (protein toxin from 
the venom of A. planci) 
Anti-proliferative effect on A375.S2 cell line 
Acanthaglycoside A 
Maculatoside 
Inhibition of colony formation of HT-29 and 
MDA-MB-231 cell lines; prevention of the 
migration of MDA-MB-231 cells 
Anthenosides A2 Reduction of T-47D cell colony number 
Polysaccharides (from A. 
pectinifera) 
Chemopreventive effect on human colon 
adenocarcinoma and human breast cancer cells 
Cariniferoside F, 
Halityloside A 
6-O-sulfate, 
4′-O-methylhalityloside A 
6-O-sulfate 
Inhibition of colony formation of RPMI-7951 
and T-47D cell lines 
Regularoside A 
Thornasteroside A 
Inhibition of colony formation of HCT-116, 
RPMI-7951 and 
T-47D cells 
Luzonicoside A 
Inhibition of proliferation, migration and 
colony formation of RPMI-7951 and SK-MEL-28 
cell lines 
Hippasterioside D 
Reduction of colony number and colony size of 
HT-29 cells 
Leptasterioside A Inhibition of colony formation of T-47D cells 
Leptaochotensoside A Reduction of colony formation of T-47D cells 
Lethasteriosides A 
Inhibition of colony formation of T-47D, 
HCT-116 and 
RPMI-7951 cell lines 
 
Once the effect of these compounds was evaluated, the researchers’ attention has focused on the 
mechanisms of action through which steroidal glycosides exert their biological activities. The 
investigations revealed that the promotion of apoptosis is the main mechanism behind cytotoxicity. 
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Apoptosis, also known as programmed cell death, is an evolutionary-conserved process involved in 
organism development and tissue homeostasis. There are two types of apoptosis program, i.e., 
intrinsic (or mitochondrial) and extrinsic (or death receptor-mediated). Both pathways entail the 
activation of initiator caspases (9 and 8, respectively), which in turn start a cascade of proteolytic 
cleavages involving effector caspases responsible for the execution phase of apoptosis. 
Effector caspases also act on the integrity of the cytoskeleton, and on components of the cell cycle 
and signal transduction pathways thereby contributing to the onset of the morphological hallmarks 
of apoptosis (chromatin condensation, nuclear fragmentation, rounding up of the cell and reduction 
in cell volume). The apoptotic trigger that activate the mechanism is regulated by the balance between 
pro-apoptotic and anti-apoptotic members of the Bcl-2 family proteins. Bcl-2, Bcl-xL, Mcl-1, Bcl-w, 
A1/Bfl-1, and Bcl-B/Bcl2L10 belong to the anti-apoptotic category, while Bax, Bak, and Bok/Mtd are 
examples of pro-apoptotic proteins. In pathological conditions, such as cancer, cells acquire the ability 
to escape apoptosis through several mechanisms, leading to their uncontrolled proliferative 
behaviour. However, the most common molecular basis of the onset of apoptosis is certainly the 
alteration of the ratio between pro-apoptotic and anti-apoptotic proteins [92–94]. Hence, the research 
and identification of new natural compounds capable to induce the apoptosis in cancer cells is a 
hopeful approach to reduce or arrest tumor growth. In this context, several studies have emphasized 
the potential of the examined polyhydroxysteroidal glycosides and asterosaponins to regulate the 
expression of apoptotic protein. Indeed, these compounds trigger a down-regulation of the 
expression of anti-apoptotic proteins (e.g., Bcl-2) and an up-regulation of that of pro-apoptotic 
proteins (e.g., Bax) in cancer cells, as shown by the biological assays. Furthermore, some evidence 
demonstrated also that steroidal glycosides from starfishes could regulate two pathways, i.e., those 
involving mitogen-activated protein kinases (MAPKs) and PI3K/AKT, which control several 
intracellular processes, including apoptosis. Three subfamilies of MAPKs have been identified: 
extracellular signal-regulated kinase (ERK; ERK1 and ERK2), c-Jun N-terminal kinase (JNK; JNK1, 
JNK2, and JNK3), and p38-MAP kinase (α, β, δ, and γ), while the PI3K/Akt signaling pathway is one 
of the best-characterized with regard to the transmission of anti-apoptotic signals in cell survival. 
These compounds have very peculiar properties, especially considering that, in bibliography, 
animals such as starfish are unknown to develop tumors, so it may be surprising the presence of 
substances capable of exerting this effect. Actually, the secondary metabolites of marine organisms 
represent “weapons”, defense strategies against extraneous and harmful agents. It can therefore be 
assumed that the effect of these molecules derives from an intrinsic cytotoxicity towards non-self. 
Indeed, some studies have shown that molecules extracted from starfish, like Granulatoside D and 
Asterosaponins 1 and 3, exert a cytotoxic effect even on non-tumor cell lines, respectively, murine 
splenocytes [65], and rabbit erythrocytes [74].  
22. Conclusions 
As mentioned above, the growing interest to develop and employ new natural compounds in 
medical field arises from the need to obtain effective drugs against cancer, especially for those types 
that are currently intractable, and from the requirement for minimal adverse-side effects on human 
health. For this purpose, the ocean, thanks to its huge biodiversity and to the peculiar characteristics 
of secondary metabolites produced from marine organisms, constitutes an invaluable and promising 
resource for years now. Echinoderms constitute a big important source of bioactive molecules, as 
confirmed by the great number of studies performed by researchers during this decade. Sea 
cucumber are the most studied group and represent an excellent source of triterpene glycosides, the 
whose effects are widely confirmed in the literature [95–97]. Further, sea urchins have been the object 
of several studies, which have revealed the potential of biomolecules such as antimicrobial peptides 
[98–100]. Within this context, starfishes found clearly their considerable position among echinoderms 
because of the biological potential of their derived compounds. Moreover, a recent study reports for 
the first time the isolation and the structural characterization of a novel cysteine-rich antimicrobial 
peptide from an extract of the coelomic epithelium of the starfish Asterina pectinifera [101]. Sometimes, 
the comparison of marine-derived compounds with drugs typically employed to treat tumors has 
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been surprising, as demonstrated, for example, by the study conducted by Mutee et al. [20] according 
to which the raw extract of A. planci was more effective compared to the chemotherapeutic drug 
Tamoxifen, commonly used against breast cancer. Moreover, some of the species from which the 
molecules have been extracted are edible, as in the case of sea urchins, sea cucumbers and even 
starfish that are included in the diet in some Asian countries, underlining the safety of natural 
substances compared to chemically synthesized. The discovery and development of marine-derived 
anticancer drugs enabled not only direct clinical benefits but also promoted the discovery of new 
mechanisms of action and molecular targets as associated scientific outcomes, making possible the 
development of alternative chemotherapeutic agents, the better understanding of the carcinogenic 
events and the subsequent progression of the disease [102]. To date, the studies carried out appear to 
provide solid bases to establish that starfishes, along with the other classes of echinoderms, could 
effectively contribute to the prevention and the treatment of several types of human cancer. However, 
further investigations are needed to get more insight into the mechanisms of action of the isolated 
biological compounds since most published works do not include any information about them. 
Furthermore, usually these compounds are tested only in vitro, and their biological properties could 
not be confirmed when tested in vivo. As regards sea stars, the only example of an in vivo study is 
that conducted by Du et al. [35], about the cerebrosides derived from the starfish Asterias amurensis. 
To our knowledge, there are no other cases in the literature to date. However, for other species of 
marine organisms, in vivo analyses have confirmed successfully the in vitro results, and thereby they 
would seem to present excellent opportunity. This is illustrated by the study of Steiner et al. [103] in 
which in vivo experiments in myeloma xenografts on chicken embryos revealed significant 
suppression of myeloma-induced neoangiogenesis close to xenografts and a reduced 
revascularization of xenografts following exposure to marine compounds, even at low 
concentrations. Other interesting examples are the study of Krishnan et al., [104] whose investigation 
evaluated the anticancer activity of crude methanolic extract of Tetilla dactyloidea (CMETD) on 
diethylnitrosamine (DEN) induced hepatocellular carcinoma in a rat model showing a potent anti-
carcinogenic effect, and the recent study of Yuan and collaborators which evaluated the antitumor 
potentiality of TBL-12, a new sea cucumber extract, in xenograft prostate cancer mice in vivo [105]. 
Anyway, once established the pharmaceutical potential of marine compounds the unavoidable 
following step is their chemical synthesis. For instance, to date, several saponins derived from marine 
organisms have been synthesized, as recently reviewed by Xiao [106]. A critical issue in the 
developmental process of drug from marine organisms is the availability of adequate amount of the 
animals and their derived compounds without harming the marine environment. Indeed, the 
extraction of these biological products involves the sacrifice of the animals and the large-scale 
production of them would lead to the extinction of species and to a significant alteration of ocean 
ecosystems. Accordingly, the characterization of the molecular structures of the extracted 
compounds is certainly a priority, in order to obtain the molecules through organic synthesis in the 
laboratory, with the aim to give an important contribution to the medical field while ensuring the 
safeguard of biodiversity. Moreover, the progress of genetic engineering, whose purpose is to transfer 
the genetic information of the desired compound in the host cells, provides a better control of the 
isolation and the expression of genes of the marine organisms, helping to have a more targeted 
approach in the development of lead compounds from the marine environment [107]. 
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